Biotechnology - Monoclonal Antibodies

Why Biotechnology Monoclonal Antibodies?

In this section you can learn and practice Biotechnology Questions based on "Monoclonal Antibodies" and improve your skills in order to face the interview, competitive examination and various entrance test (CAT, GATE, GRE, MAT, Bank Exam, Railway Exam etc.) with full confidence.

Where can I get Biotechnology Monoclonal Antibodies questions and answers with explanation?

IndiaBIX provides you lots of fully solved Biotechnology (Monoclonal Antibodies) questions and answers with Explanation. Solved examples with detailed answer description, explanation are given and it would be easy to understand. All students, freshers can download Biotechnology Monoclonal Antibodies quiz questions with answers as PDF files and eBooks.

Where can I get Biotechnology Monoclonal Antibodies Interview Questions and Answers (objective type, multiple choice)?

Here you can find objective type Biotechnology Monoclonal Antibodies questions and answers for interview and entrance examination. Multiple choice and true or false type questions are also provided.

How to solve Biotechnology Monoclonal Antibodies problems?

You can easily solve all kind of Biotechnology questions based on Monoclonal Antibodies by practicing the objective type exercises given below, also get shortcut methods to solve Biotechnology Monoclonal Antibodies problems.

Exercise :: Monoclonal Antibodies - Section 1

  • Monoclonal Antibodies - Section 1
1. 

The approach (s), which is/are currently followed to produce human monoclonal antibodies, is/are known as

A. transformation of antigen specific B lymphocytes (EBV)
B. hybridization of 6-thioguanine-resistant human plasmacytoma with immune human lymphocytes
C. combination of EB Vand hybridoma techniques
D. all of these

Answer: Option D

Explanation:

No answer description available for this question. Let us discuss.

2. 

Some cross reactions with monoclonal antibodies (MAbs) can occur. Unexpected cross reactions occur more frequently with

A. Ig MAbs
B. IgG
C. IgA
D. IgE

Answer: Option A

Explanation:

No answer description available for this question. Let us discuss.

3. 

Preliminary clinical results with a humanized antibody against the interleukin-2 receptor have suggested the

A. absence of human immune response against murine proteins (HAMA) response
B. presence of HAMA response
C. poor recognition of immunoglobulin, Ig constant regions
D. all of the above

Answer: Option A

Explanation:

No answer description available for this question. Let us discuss.

4. 

The cross linkage of antigens by antibodies is known as

A. agglutination
B. complement fixation
C. a cross reaction
D. all of these

Answer: Option A

Explanation:

No answer description available for this question. Let us discuss.

5. 

In monoclonal antibody technology, tumor cells that can replicate endlessly are fused with mammalian cells that produce an antibody. The result of this cell fusion is a

A. hybridoma
B. myeloma
C. natural killer cell
D. lymphoblast

Answer: Option A

Explanation:

No answer description available for this question. Let us discuss.